Skip to main content

Thoracic Surgery and Esophagectomy

  • Reference work entry
  • First Online:
Oncologic Critical Care

Abstract

Esophageal cancer is ranked sixth in mortality and classified as the eighth most common cause of cancer [30]. It is classified by two main histological types squamous-cell carcinoma and adenocarcinoma. Both types of malignancy differ in regard to incidence, etiology, risk factors, and population affected. Esophageal squamous-cell carcinoma has been associated with smoking, heavy alcohol use, red meat consumption, hot beverage drinking, poor oral health, low intake of fresh fruits and vegetables, and low socioeconomic status. Obesity, gastroesophageal reflux disease, and Barrett’s esophagus have been recognized as high-risk factors for adenocarcinoma of the esophagus. There are several conditions and lesions that are considered premalignant and may lead to the development of esophageal carcinoma.

Esophageal cancer is typically three to four times more common among males than in females and slightly deadlier in men than women. The most common presenting symptom in esophageal cancer is dysphagia. The majority of patients do not present with premalignant or early-stage disease but with advanced locoregional and metastatic disease. Proper histopathological diagnosis and staging are crucial in determining the adequate management of patients with esophageal cancer. There are a wide variety and combination of treatments including chemotherapy, radiation, endoscopic procedures, and surgery. Major morbidity after esophagectomy can be up to 65%. Anastomotic leak and pulmonary complications are among the most reported complications. Esophagogastric anastomotic leak accounts for 40% of postoperative fatalities after esophagectomy. The incidence is 4–17%, and the etiology is multifactorial. The 5-year survival rate for patients able to undergo resection is 47%.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 949.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 1,299.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Aday U, Gündeş E, Ali Çetin D, et al. Long-term evolution of squamous-cell cancer in Plummer-Vinson syndrome. Przegla̜d Gastroenterologiczny. 2017;12(3):226–8.

    PubMed  PubMed Central  Google Scholar 

  2. Ajani JA, D’Amico TA, Almhanna K, et al. Esophageal and esophagogastric junction cancers, version 1.2015: clinical practice guidelines in oncology. J Natl Compr Cancer Netw. 2015;13(2):194–227.

    Article  CAS  Google Scholar 

  3. American Cancer Society (2018) Cancer facts & figures 2018. https://www.cancer.org/research/cancer-facts-statistics/all-cancer-facts-figures/cancer-facts-figures-2018.html

  4. Blum MA, Taketa T, Sudo K, et al. Chemoradiation for esophageal cancer. Thorac Surg Clin. 2013;23:551–8.

    Article  Google Scholar 

  5. Colwell EM, Encarnacion CO, Rein LE, et al. Atrial fibrillation after transhiatal esophagectomy with transcervical endoscopic esophageal mobilization: one institution’s experience. J Cardiothorac Surg. 2018;13:73.

    Article  Google Scholar 

  6. Contini S, Scarpignato C. Caustic injury of the upper gastrointestinal tract: a comprehensive review. World J Gastroenterol. 2013;19(25):3918–30.

    Article  Google Scholar 

  7. Crumley S, Schraag S. The role of local anaesthetic techniques in ERAS protocols for thoracic surgery. J Thorac Dis. 2018;10(3):1998–2004. https://doi.org/10.21037/jtd.2018.02.48.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Cuellar SL, Carter BW, Macapiinlac HA, et al. Clinical staging of patients with early esophageal adenocarcinoma: does PDG-PET/CT have a role? J Thorac Oncol. 2014;9(8):1202–6.

    Article  CAS  Google Scholar 

  9. D’Amico TA. Mckeown esophagogastrectomy. J Thorac Dis. 2014;6(Suppl 3):S322–4.

    PubMed  PubMed Central  Google Scholar 

  10. Ellis A, Risk JM, Maruthappu T, et al. Tylosis with oesophageal cancer: diagnosis, management and molecular mechanisms. Orphanet J Rare Dis. 2015;10: 126.

    Article  Google Scholar 

  11. Enzinger PC, Mayer RJ. Esophageal cancer. N Engl J Med. 2003;349(23):2241–52.

    Article  CAS  Google Scholar 

  12. Herbella FA, Dubecz A, Patti MG. Esophageal diverticula and cancer. Dis Esophagus. 2012;25(2):153–8.

    Article  CAS  Google Scholar 

  13. Hikage M, Kamei T, Nakano T, Abe S, Katsura K, Taniyama Y, Sakurai T, Teshima J, Ito S, Niizuma N, Okamoto H, Fukutomi T, Yamada M, Maruyama S, Ohuchi N. Impact of routine recurrent laryngeal nerve monitoring in prone esophagectomy with mediastinal lymph node dissection. Surg Endosc. 2017;31(7): 2986–96.

    Article  Google Scholar 

  14. Hofstetter WL. Salvage esophagectomy. J Thorac Dis. 2014;6(3):341–9.

    Google Scholar 

  15. Kim H, Park H, Choi HS, et al. Retention esophagitis as a significant clinical predictor of progression of esophageal cancer in achalasia. Clin Endosc. 2018;51(2):161–6.

    Article  Google Scholar 

  16. Lv L, Hu W, Ren Y, et al. Minimally invasive esophagectomy versus open esophagectomy for esophageal cancer: a meta-analysis. Onco Targets Ther. 2016;9:6751–62.

    Article  Google Scholar 

  17. Ma G-W, Situ D-R, Ma Q-L, et al. Three-field vs two-field lymph node dissection for esophageal cancer: a meta-analysis. World J Gastroenterol. 2014;20(47): 18022–30.

    Article  Google Scholar 

  18. Miao L, Zhang Y, Hu H, Ma L, Shun Y, Xiang J, Chen H. Incidence and management of chylothorax after esophagectomy. Thorac Cancer. 2015;6(3):354–8.

    Article  CAS  Google Scholar 

  19. Napier KJ, Scheerer M, Misra S. Esophageal cancer: a review of epidemiology, pathogenesis, staging workup and treatment modalities. World J Gastrointest Oncol. 2014;6(5):112–20.

    Article  Google Scholar 

  20. Ohi M, Toiyama Y, Omura Y, et al. Risk factors and measures of pulmonary complications after thoracoscopic esophagectomy for esophageal cancer. Surg Today. 2018; https://doi.org/10.1007/s00595-018-1721-0. [Epub ahead of print]

  21. Pennathur A, Zhang J, Chen H, et al. The “best operation” for esophageal cancer? Ann Thorac Surg. 2010;89(6):S2163–7.

    Article  Google Scholar 

  22. Rice TW, Patil DT, Blackstone EH. 8th edition AJCC/UICC staging of cancers of the esophagus and esophagogastric junction: application to clinical practice. Ann Cardiothorac Surg. 2017;6(2):119–30.

    Article  Google Scholar 

  23. Sakatoku Y, Fukaya M, Fujieda H, et al. Tracheoesophageal fistula after total resection of gastic conduit for gastro-aortic fistula due to gastric ulcer. Surg Case Rep. 2017; https://doi.org/10.1186/s400792-017-0371-6.

  24. Shridhar R, Takahashi C, Huston J, et al. Anastomotic leak and neoadjunctive chemotherapy in esophageal cancer. J Gastrointest Oncol. 2018;9(5):894–902.

    Article  Google Scholar 

  25. Svetanoff WJ, McGahan R, Singhal S, et al. Quality of life after esophageal resection. Patient Relat Outcome Meas. 2018;9:137–46.

    Article  Google Scholar 

  26. Torre LA, Siegel RL, Ward EM, et al. Global cancer incidence and mortality rates and trends – an update. Cancer Epidemiol Biomarkers Prev. 2016;25(1): 16–27.

    Article  Google Scholar 

  27. Van Workum F, Berkelmans GH, Klarenbeek BR, et al. McKeown or Ivor Lewis totally minimally invasive esophagectomy for cancer of the esophagus and gastroesophageal junction: systematic review and meta-analysis. J Thorac Dis. 2017;9(Suppl 8):S826–33.

    Article  Google Scholar 

  28. Veelo DP, Geerts BF. Anaesthesia during oesophagectomy. J Thorac Dis. 2017;9(Suppl 8):S705–12.

    Article  Google Scholar 

  29. Yoshida N, Watanabe M, Baba Y, Iwagami S, Ishimoto T, Iwatsuki M, Sakamoto Y, Miyamoto Y, Ozaki N, Baba H. Risk factors for pulmonary complications after esophagectomy for esophageal cancer. Surg Today. 2014;44(3):526–32.

    Article  Google Scholar 

  30. Zhang Y. Epidemiology of esophageal cancer. World J Gastroenterol. 2013;19(34):5598–606.

    Article  Google Scholar 

  31. Zhou C, Ma G, Li X, et al. Is minimally invasive esophagectomy effective for preventing anastomotic leakages after esophagectomy for cancer? A systematic review and meta-analysis. World J Surg Oncol. 2015;13:269.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Section Editor information

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Switzerland AG

About this entry

Check for updates. Verify currency and authenticity via CrossMark

Cite this entry

Puskac, M.M., Hetz, R.A. (2020). Thoracic Surgery and Esophagectomy. In: Nates, J., Price, K. (eds) Oncologic Critical Care. Springer, Cham. https://doi.org/10.1007/978-3-319-74588-6_166

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-74588-6_166

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-74587-9

  • Online ISBN: 978-3-319-74588-6

  • eBook Packages: MedicineReference Module Medicine

Publish with us

Policies and ethics